A Society-to-Cells approach to evaluating multilevel and interrelated drivers of breast cancer disparities in Black women
View abstract on PubMed
Summary
This summary is machine-generated.Black women face aggressive breast cancer and higher mortality due to systemic factors. Addressing root causes like disinvestment and healthcare bias is crucial for equity.
Area Of Science
- Health Disparities
- Oncology
- Sociomedical Sciences
Background
- Black women in the US experience disproportionately aggressive breast cancer subtypes and higher mortality rates.
- Existing advances in breast cancer detection and treatment have not fully closed this survival gap.
Purpose Of The Study
- To present a comprehensive framework, using a Society-to-Cells lens, for understanding the multilevel drivers of breast cancer disparities in Black women.
- To identify structural and cellular factors contributing to inequities in breast cancer outcomes.
Main Methods
- This study is a comprehensive review.
- It synthesizes information through a Society-to-Cells framework.
- It examines multilevel drivers from societal forces to cellular responses.
Main Results
- Multilevel drivers, encompassing structural inequities and cellular responses, interact to perpetuate breast cancer disparities.
- Historical neighborhood disinvestment and healthcare system biases are identified as key contributing factors.
Conclusions
- Addressing breast cancer inequities requires systemic reforms targeting the root causes of disparities.
- Policy interventions should focus on redressing historical disinvestment and eliminating bias within healthcare systems to improve outcomes for Black women.
Related Concept Videos
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

